Alembic Pharma JV Aleor gets USFDA nod for generic antifungal cream

New Delhi: Drug firm Alembic Pharmaceuticals on Thursday said its joint venture Aleor Dermaceuticals has received final nod from the US health regulator for antifungal Nystatin and Triamcinolone Acetonide cream used for the treatment of cutaneous candidiasis. Aleor Dermaceuticals Ltd (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Nystatin and Triamcinolone Acetonide cream USP, 1,00,000 units/gram and 1 mg/gram, Alembic Pharma said in a BSE filing.

The product is a generic version of Taro Pharmaceuticals USA Inc’s Nystatin and Triamcinolone Acetonide cream USP in the same strength, it added.

According to IQVIA, Nystatin and Triamcinolone Acetonide cream USP has an estimated market size of USD 19 million for twelve months ending December 2020, the filing said.

  • Related Posts

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    New Delhi — In a significant move to bring greater transparency and accountability in healthcare delivery, the Centre has directed all states and Union Territories to tighten regulatory oversight within…

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal Pharma Solutions, a global contract development and manufacturing organization, and Ajinomoto Bio-Pharma Services announced a strategic collaboration to support development and manufacturing of antibody-drug conjugates (ADCs) using AJICAP technology…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

    Piramal, Ajinomoto team on ADC development and manufacturing

    Piramal, Ajinomoto team on ADC development and manufacturing

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid